0001209191-17-014942.txt : 20170227 0001209191-17-014942.hdr.sgml : 20170227 20170227182511 ACCESSION NUMBER: 0001209191-17-014942 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170223 FILED AS OF DATE: 20170227 DATE AS OF CHANGE: 20170227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUBINO RICHARD J CENTRAL INDEX KEY: 0001252014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 17643785 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-23 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001252014 RUBINO RICHARD J C/O AERIE PHARMACEUTICALS, INC. 2030 MAIN STREET, SUITE 1500 IRVINE CA 92614 0 1 0 0 Chief Financial Officer Common Stock 2017-02-23 4 A 0 4780 0.00 A 403912 D Common Stock 2017-02-24 4 F 0 932 44.55 D 402980 D Common Stock 2017-02-25 4 F 0 845 44.55 D 402135 D Stock Option (right to buy) 44.25 2017-02-23 4 A 0 43019 0.00 A 2027-02-23 Common Stock 43019 43019 D These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 23, 2017. This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of February 23, 2017. /s/ Richard J. Rubino 2017-02-27